Company Snapshot Home > Equity > Corporate Information > Company Snapshot
|
|
| Stock Price Details |
|
Chart |
|
|
Last Price (RS)
|
916.60
|
|
Change (%)
|
-10.05 (-1.08%)
|
|
Best Buy (RS)
|
0(x0)
|
|
Best Sell (RS)
|
0(x0)
|
|
Today's Range (RS)
|
902.60
-
940.00
|
|
52-Week Range (RS)
|
299.63
-
999.00
|
|
Beta (1 Year)
|
0.38
|
|
|
|
|
|
| News |
|
Corporate Details |
| Fredun Pharmaceuticals to convene AGM |
| Fredun Pharmaceuticals consolidated net profit rises 79.67% in the March 2026 quarter |
| Board of Fredun Pharmaceuticals approves bonus issue of 2:1 |
| Board of Fredun Pharmaceuticals recommends final dividend |
| Fredun Pharmaceuticals standalone net profit rises 56.58% in the March 2026 quarter |
| Fredun Pharmaceuticals to announce Quarterly Result |
| Fredun Pharmaceuticals sets up its 5th manufacturing unit in Palghar |
| Fredun Pharmaceuticals allots 40,000 equity shares on conversion of warrants |
| Fredun Pharmaceuticals standalone net profit rises 96.62% in the December 2025 quarter |
| Fredun Pharmaceuticals to convene board meeting |
|
|
|
| Incoporation Year : 1987 |
| Chairman : Daulat N Medhora |
| Ownership Group : Indian Private |
| Sector : MAN |
| Industry : Pharmaceuticals - Indian - Formulations |
| Registered Office |
Fredun Pharmaceuticals Ltd 26 Manoj Industrial Premises, G D Ambedkar Marg Wadala, Mumbai, Maharashtra-400031 |
Phone:91-22-40318111 Fax: |
| E-Mail : business@fredungroup.com |
| URL : http://www.fredungroup.com |
|
| Investor Returns |
|
| |
Date |
Price |
Returns (%) |
| 1Week |
13-Jul-2026 |
917.89 |
0.95 |
| 1Month |
22-Jun-2026 |
859.14 |
7.86 |
| 3Month |
20-Apr-2026 |
689.23 |
34.45 |
| 6Month |
20-Jan-2026 |
501.61 |
84.74 |
| 1Year |
21-Jul-2025 |
316.75 |
192.55 |
|
|
|
| Mutual Funds Holding |
|
| No Data Found |
|
|
|
| Groups : Pharmaceuticals - Indian - Formulations |
|
| Company |
Last Price |
Change (%) |
52Week High |
52Week Low |
Market Cap (Rs Cr.) |
| Torrent Pharmaceuticals Ltd |
5,038.75 |
0.71 |
5,084.85 |
3,468.75 |
170,534.20 |
| Ajanta Pharma Ltd |
3,577.70 |
3.13 |
3,594.05 |
2,335.00 |
44,698.22 |
| Gland Pharma Ltd |
2,484.35 |
1.01 |
2,574.00 |
1,575.00 |
40,981.76 |
| Rubicon Research Ltd |
1,516.25 |
0.19 |
1,538.95 |
571.00 |
25,076.16 |
| ERIS Lifesciences Ltd |
1,469.15 |
0.35 |
1,887.65 |
1,237.90 |
20,359.26 |
|
|
|
|